Skip to main content
The Egyptian Journal of Bronchology
Download PDF
  • Original article
  • Open access
  • Published:

Cardiovascular comorbidities associated with patients with chronic obstructive pulmonary disease – a hospital-based study

Egyptian Journal of Bronchology volume 13, pages 591–595 (2019)Cite this article

Abstract

Background

Most patients with chronic obstructive pulmonary disease (COPD) have cardiovascular comorbidities (CVD), which significantly contribute to the mortality and morbidity in these patients.

Objective

The primary objective was to assess the prevalence of CVD in hospitalized patients with COPD. The secondary objectives were to study the risk factors associated with CVD in patients with COPD and to assess if the severity of COPD was related to the prevalence of CVD.

Patients and methods

The present study was a prospective observational study. The study period spanned from January 2013 to December 2014. All consecutive patients admitted with a diagnosis of COPD were included in the study. Patients with coexisting chronic respiratory illnesses, like obstructive sleep apnea, interstitial lung disease, and bronchiectasis, were excluded. The presence of various CVD was assessed with a history, physical evaluation, and limited tests [ECG, troponin levels, serum brain natriuretic peptide (BNP), and echocardiography). χ2 test was used to test the statistical significance. Clearance from ethical committee and consent from patients were obtained before the study.

Results

A total of 100 patients with COPD were included in the study. Overall, 60% of the patients had CVD. Common CVD were ischemic heart disease (21%), congestive heart failure (20%), stroke (5%), and arrhythmias (3%). The prevalence of CVD among patients with stages 1 and 2 COPD was 44.4%, stage 3 COPD was 61.5% and stage 4 COPD was 66.7% (P=0.298). Using multiple linear regression analysis, significant risk factors for CVD were serum BNP levels [P=0.001; odds ratio (OR), 17.5], dyslipidemia (P=0.037; OR, 3.6), and systemic hypertension (P=0.002; OR, 4.6). Patients with COPD and CVD had a lower BMI as compared with those without CVD.

Conclusion

Ischemic heart disease, congestive cardiac failure, and stroke were the most commonly identified CVD in patients with COPD. Systemic hypertension, dyslipidemia, and serum BNP levels were identified as important predictors for CVD in our study.

References

  1. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58:388–393.

    Article  CAS  Google Scholar 

  2. Curkendall S, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring E, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16:63–70.

    Article  Google Scholar 

  3. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128:2640–2646.

    Article  Google Scholar 

  4. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from?A multiple cause coding analysis. Eur Respir J 2003; 22:809–814.

    Article  CAS  Google Scholar 

  5. Mannino DM, Doherty DE, Buist AS. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100:115–122.

    Article  Google Scholar 

  6. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2012. Available from: http://goldcopd.org

  7. Gupta R. Burden of coronary heart disease in India. Indian Heart J 2005; 57:632–638.

    PubMed  Google Scholar 

  8. Gupta R. Coronary heart disease in India: absolute numbers and economic burden. Rapid response to Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. Br Med J 2004; 328:807–810.

    Article  Google Scholar 

  9. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 65:956–962.

    Article  Google Scholar 

  10. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009; 4:337–349.

    Article  Google Scholar 

  11. Agusti A, Calverley PMA, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11:122.

    Article  Google Scholar 

  12. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32:962–969.

    Article  CAS  Google Scholar 

  13. Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 2008; 63:599–605.

    Article  CAS  Google Scholar 

  14. King DA, Cordova F, Scharf SM. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5:519–523.

    Article  Google Scholar 

  15. Harik-Khan RI, Fleg JL, Wise RA. Body mass index and the risk of COPD. Chest 2002; 121:370–376.

    Article  Google Scholar 

  16. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 2006; 368:666–678.

    Article  Google Scholar 

  17. Lusis AJ. Atherosclerosis. Nature 2000; 407:233–241

    Article  CAS  Google Scholar 

  18. Verma S, LiSH, Badiwala MV, Weisel RD, Fedak PW, LiRK, et al. Endothelin antagonism and interleukin 6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002; 105:1890–1896.

    Article  CAS  Google Scholar 

  19. Chang CL, Robinson SC, Mills GD, Sullivan GD, Karalus NC, McLachlan JD, Hancox RJ. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbation of COPD. Thorax 2011; 66:764–768.

    Article  Google Scholar 

  20. McCullogh PA, Hollander JE, Nowak RM, Storrow AB, Duc P, Omland T, et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type Natriuretic peptide in the emergency department. Acad Emerg Med 2003; 10:198–204.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pulmonary Medicine, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India

    Amit S. Gupta MD

  2. Department of Pulmonary Medicine, Rajagiri Hospital, India

    Venkitakrishnan Rajesh

  3. Department of Pulmonary Medicine, Amrita Institute of Medical Sciences, Kochi, Kerala, India

    Ponneduthamkuzhy James

Authors
  1. Amit S. Gupta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Venkitakrishnan Rajesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ponneduthamkuzhy James
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amit S. Gupta MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, A.S., Rajesh, V. & James, P. Cardiovascular comorbidities associated with patients with chronic obstructive pulmonary disease – a hospital-based study. Egypt J Bronchol 13, 591–595 (2019). https://doi.org/10.4103/ejb.ejb_64_19

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejb.ejb_64_19

Keywords